Phosphate Binders

Raising Lanthanum Dose Cuts Phosphorus Levels

PARIS—Raising the dose of the calcium-free phosphate binder lanthanum carbonate from a lower conventionally used dose of 2,250 or less to 3,000 mg/day may reduce phosphorus levels in patients with chronic kidney disease (CKD) and hyperphosphatemia.

Next post in NKF 2010 Hyperphosphatemia